The Business of Genomics: AI, Regulation & Point-of-Care Diagnostics Explained скачать в хорошем качестве

The Business of Genomics: AI, Regulation & Point-of-Care Diagnostics Explained

How do you turn genomic innovation into commercial reality? Dr. Daniel Farkas, a leader in molecular diagnostics for over three decades, joins The Helix Exchange to break down what it really takes to bring genomic technologies from lab bench to clinical practice. In this episode: The three components of every clinical test Why reimbursement can make or break a biotech company The realities of point-of-care molecular diagnostics Multi-omics and population-scale data AI’s true opportunity in genomic analysis Why healthcare technology must be dramatically better to replace existing systems Genomics is no longer just about discovery — it’s about execution. 🎧 Watch now to understand where regulation, data, and innovation intersect in the genomics economy.